{"name":"Trigone Pharma Ltd.","slug":"trigone-pharma-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxPVmY3bzdxV016RkdZNW9CR0xZcTZiYjRKM3g3SWdaR0R1ejJuNzlqeU42cno2UllMbHR1VFB6Y0kxWDJpYVBTU1VhOU1rNzdEcmpDNEc2ZGNLcmlxRnNGb09UQy11MzlDZkducEtKYkZ6dFhxU1d3NEd4QkpNdUFDQUUtNDdjMmVodFVfWmUtRmkyM2M0bDMtNkNVeEVyOWNOcFkySkRRV3BRZ0docXhnWDY2cjVTY0plRHUwR2dpM19RQmJmbDlUSVRNWDFjbWhiYzZ2cVRrcVhiQS1vSW1XajgtOVBoNUVtY2UxZjJWcFpXMGFUMDVNRk9wdTQyakhtYmFxZUtLSjlkUzBod2dETk1uMzc1YjRKRWpMZlc1bkJoeW1VeE91ODFUem1zSGo2R3h5MWs4ZGZuRkJWZF9QLUs4MDhxLXhRNklJTFpMYmstUmtDNkVF?oc=5","date":"2026-03-30","type":"pipeline","source":"globenewswire.com","summary":"Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow - globenewswire.com","headline":"Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPdWpfRE9DNFBKQTFKRXZxU19sY0tFVnM0NGFfVjRTdkxSSDY5OW9fRzZEMjhMWEE2Vkp2S1dha3RjZU1xTVBhcENZbjE2aHRMTW5iU0tydFRKSUREWHBHRUwzWWxVTGQxRjAza1BJaktUTFNtaUE4allvLU14WU0ybWZSMm9zOXVEVnNWY1Y4ckFRajlUendLZU1LSUZFbTZ6VTRpN2ZNYkUzRHFLdlZWakZ2bjZiX18xRVIzYjNRNld5QmQ2cEdqYWswdHJCVzk3Y0s5YS1DYVZwbVlGb1NvMmpvUjNQamhhaEx1SGlGeXdyRUN0SlhvbkJjYkF2dTd4bTktWFZOalQtRTJiTVVOampJZmVNOEV2eG1MV1pXWEpYRlduMWpZSnFnVTVHSWE2TjV4YVhCN2JIX1Z1dkFTZVpqblA5endudkRoeHRDdTdzZw?oc=5","date":"2026-03-25","type":"pipeline","source":"Barchart.com","summary":"Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma - B","headline":"Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPUi1PZTA4RnhTUU1RUmRITlpoZGZCaFp6ZEZEYS1HdTQ5V1pWUFNIWC1LVWpYaDRfRWxHRkE0RGNXcDhOUUN4NHY0bXV3dUdNOWoyMGoyZzJxbEszdFF1Zm9Jc2QxeHR0OHR6djBNeHRnTWZ4VmNTWms1dUNCRDFXRkdudEpaZ240ZVR0TG05eW1URS0wdzI4Um9pMDIzTU9pQWJIRklodUY0MGh6NGNlanZ3dXUzdjNsN0hDU0JpUU8yS1V2RV9IWGtJVEhfRVMtQXp1TVB0SFgyLU1hVnE4UjJYcVV3MmcyNV9sQUMxVUg1TTNadkN0Tzl1anN1aVgtY3dXLWQtam1kMXRoQS1XVlVLMUhjUQ?oc=5","date":"2026-03-25","type":"trial","source":"Barchart.com","summary":"Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering N","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPUWRsVlFKWGJSNTlzaFpub25UQ3JySkZwcGtvRGNMM2htSzR0RW1Eek5WRl9xMUpzQnlDa2ROT0cyUk5ZSTRXSTNQcjUxd2Z2T2pkZm04LWNidExyTm9SR2ZoYkdBUlcwLS1wUXpwREtXVkd6ZWdpN2FmSVhpa0NUaTVtVlh0MDhtWVNPdEpxU3UwMllPR1lDTUdB?oc=5","date":"2026-03-25","type":"trial","source":"openPR.com","summary":"Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline - openPR.com","headline":"Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPUUU2U3Vzeno3S09pTWpPeDlCWWtvNHREZGI4SURXWm5VdV83dml2R21iZ2txM1NxWGVpRlIzd2l3UHNtNm9BcXlkQ0ctNE9WZXVmX1hQX3dsX2pjSUFJeEpIMjhGR3VadURnS09wUW1xOGlCRG1SUWlYOV96dnoxeDNXMkotMlNpU2VtTF9YWXY?oc=5","date":"2021-08-13","type":"trial","source":"Yahoo Finance","summary":"Trigone Pharma Announces the Initiation of a Phase 2 Clinical Trial of TRG-100 in Patients with Interstitial Cystitis/Bladder Pain Syndrome - Yahoo Finance","headline":"Trigone Pharma Announces the Initiation of a Phase 2 Clinical Trial of TRG-100 in Patients with Interstitial Cystitis/Bl","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-07-22","type":"trial","source":"globenewswire.com","summary":"Trigone Pharma to Present Preclinical Data for TRG-100 in - globenewswire.com","headline":"Trigone Pharma to Present Preclinical Data for TRG-100 in","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}